Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01085539 · ClinicalTrials.gov registry record
Oxygen Saturation Alarms in the Neonatal Intensive Care Unit
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 50
- Enrollment target
NCT01085539: Completed study, sponsored by Medtronic - MITG.
NCT01085539 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01085539 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Infants will be observed in the neonatal intensive care unit for 4 hours. The observer will note the timing of oxygen saturation alarms, staff response, and interrupted staff activities.
Primary Outcome
Sat Secs is an oxygen alarm with 5 settings:0,10,25,50,and 100. At each setting,using the units of seconds,it filters nusiance alarms \& identifies important alarms that result in the clinicians changing the care of the infant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-06 |
What the finished NCT01085539 record still lists
NCT01085539 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01085539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01085539 about?
NCT01085539 is a clinical study titled "Oxygen Saturation Alarms in the Neonatal Intensive Care Unit". Infants will be observed in the neonatal intensive care unit for 4 hours. The observer will note the timing of oxygen saturation alarms, staff response, and interrupted staff activities.
What is the current status of trial NCT01085539?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-01. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT01085539?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia